8.39 (2H, s, ArH); 13C NMR (101 MHz, CDCl3) d 18.7, 24.3, 36.1,
86.0, 86.5, 115.7, 122.5, 127.0, 128.0, 128.4, 128.5, 136.0, 136.6,
137.8, 145.0, 156.7, 161.0; IR (KBr) mmax 2366, 2341, 1594, 1498,
1436, 1422, 1326, 1195, 1159, 1141, 1099, 1023, 938, 916, 761,
700 cm−1; MS (MALDI-TOF) m/z 686 (M + H); Anal. calcd for
C46H40N2O4: C, 80.68; H, 5.89; N, 4.09. Found: C, 80.50; H, 5.77;
N, 4.06.
865 cm−1; MS (CI) m/z (rel. intensity) 213 [M(81Br) + H, 97], 211
[M(79Br) + H, 100]; Anal. calcd for C9H10NBr: C, 50.97; H, 4.75;
N, 6.60. Found: C, 50.66; H, 4.73; N, 6.39.
(7R,S)-7-Acetoxy-2-bromo-4-methyl-6,7-dihydro-5H-[1]pyridine
(12)
To a stirred solution of the 2-bromopyridine 11 (2.20 g, 10.4 mmol)
in glacial acetic acid (20 mL) was added an aqueous solution of
hydrogen peroxide (30% w/w, 5.0 mL, 49 mmol). The resultant
solution was heated at 80 ◦C for 20 h and then was allowed to
cool to room temperature. The reaction mixture was concentrated
in vacuo and the residue was taken up in water (100 mL). The
resultant slightly acidic mixture was neutralized by the careful
addition of solid potassium carbonate which was then extracted
with chloroform (3 × 50 mL). The combined organic extracts were
dried over anhydrous sodium sulfate and concentrated in vacuo to
afford the pyridine N-oxide (2.35 g, 99%) as a white crystalline
solid. This material was taken up in acetic anhydride (20 mL) and
4-Methyl-2-(2ꢀ-pyridyl)-6,7-dihydro-5H-[1]pyridin-7-one-(1S,2S)-
1,2-diphenyl-1,2-ethanediol acetal (2b). Representative procedure
for the preparation of the unsymmetric 2,2ꢀ-bipyridyl ligands
(2a–b) from the 2-chloropyridine acetals (3a and 3c)
To a stirred solution of the 2-chloropyridine acetal 3c23 (261 mg,
0.690 mmol) and 2-(tri-n-butylstannyl)pyridine8a (472 mg, 0.759
mmol) in anhydrous, degassed dioxane (5 mL) at room tempera-
ture were added tris(dibenzylideneacetone)dipalladium(0) (16 mg,
17 lmol), a solution of tri-t-butylphosphine in tetrahydrofuran
(0.10 M, 0.69 mL, 69 lmol) and anhydrous cesium fluoride
(231 mg, 1.52 mmol). The resultant solution was heated at reflux
for 24 h and then was allowed to cool to room temperature. The
reaction mixture was filtered through a pad of silica gel using ethyl
acetate as the eluant and the filtrate was then concentrated in vacuo
to afford the crude product. Flash chromatography using hexanes–
ether (4 : 1) as the eluant afforded the title compound 2b (242 mg,
83%) as a white crystalline solid. Mp 120–121 ◦C, hexanes–ether;
◦
the reaction mixture was heated slowly to 100 C over 2 h. The
◦
resultant mixture was heated at 100 C for 2 h and then allowed
to cool to room temperature. The reaction mixture was then
concentrated in vacuo and purified by flash chromatography using
hexanes–ether (1 : 1) as the eluant to afford the title compound 12
(1.50 g, 54% over two steps) as a light orange oil which crystallized
upon standing. Mp 68–69 ◦C; 1H NMR (400 MHz, CDCl3) d 2.00–
2.11 (4H, m, ArCH2CHH and CH3CO), 2.26 (3H, s, ArCH3),
2.68–2.69 (1H, m, ArCH2CHH), 2.69–2.80 (1H, m, ArCHH),
2.87–2.98 (1H, m, ArCHH), 5.98–6.02 (1H, m, CHOAc), 7.22
(1H, s, ArH); 13C NMR (101 MHz, CDCl3) d 18.7, 21.5, 26.3,
30.6, 122.9, 136.9, 141.5, 147.2, 160.8, 170.8; IR (KBr) mmax 2363,
2337, 1734, 1653, 1635, 1559, 1541, 1507, 1370, 1337, 1235, 1094,
1036, 856 cm−1; MS (CI) m/z (rel. intensity) 272 [M(81Br) + H,
97], 270 [M(79Br) + H, 100], 212 (30), 101 (35); Anal. calcd for
C11H12NO2Br: C, 48.91; H, 4.48; N, 5.19. Found: C, 48.63; H,
4.43; N, 5.32.
1
[a]2D0 −98.4 (c 1.00, chloroform); H NMR (400 MHz, CDCl3) d
2.40 (3H, s, ArCH3), 2.68–2.82 (2H, m, ArCH2CH2), 2.96–3.03
(2H, m, ArCH2), 4.92 (1H, d, J = 8.5 Hz, CH), 5.77 (1H, d, J =
8.5 Hz, CH), 7.29–7.37 (9H, m, ArH), 7.61–7.66 (2H, m, ArH),
7.80–7.86 (1H, m, ArH), 8.30 (1H, s, ArH), 8.52–8.56 (1H, m,
ArH), 8.67–8.71 (1H, m, ArH); 13C NMR (101 MHz, CDCl3) d
18.5, 24.3, 36.1, 86.1, 86.5, 115.6, 121.4, 122.2, 123.6, 126.9, 127.9,
128.4, 128.5, 128.5, 136.5, 137.1, 137.5, 145.4, 149.0, 156.7, 161.2;
IR (KBr) mmax 1586, 1564, 1492, 1441, 1381, 1351, 1320, 1289,
1253, 1210, 1185, 1164, 1103, 1056, 1021, 936, 920, 796, 761, 751,
700 cm−1; MS (CI) m/z (rel. intensity) 421 (M + H, 90), 314 (2),
225 (100); Anal. calcd for C28H24N2O2: C, 79.98; H, 5.75; N, 6.66.
Found: C, 79.64; H, 6.02; N, 6.30.
(7R,S)-2-Bromo-4-methyl-6,7-dihydro-5H-[1]pyridin-7-ol (13)
A stirred solution of the acetate 12 (1.50 g, 5.55 mmol) and lithium
hydroxide monohydrate (932 mg, 22.2 mmol) in tetrahydrofuran
(15 mL) and water (5 mL) was stirred at room temperature
for 5 h. The reaction mixture was then diluted with water (25
mL) and extracted with chloroform (3 × 25 mL). The combined
organic extracts were dried over anhydrous sodium sulfate and
concentrated in vacuo to afford the crude product. Flash chro-
matography using hexanes–ether (1 : 1) as the eluant afforded the
title com◦pound 13 (1.20 g, 95%) as a white crystalline solid. Mp
110–111 C, hexanes–ether; 1H NMR (400 MHz, CDCl3) d 1.99–
2.12 (1H, m, ArCH2CHH), 2.26 (3H, s, ArCH3), 2.48–2.59 (1H,
m, ArCH2CHH), 2.63–2.75 (1H, m, ArCHH), 2.87–2.97 (1H, m,
ArCHH), 5.18 (1H, apparent t, J = 7.2 Hz, CHOH), 7.19 (1H, s,
ArH); 13C NMR (101 MHz, CDCl3) d 18.6, 25.8, 32.2, 74.8, 127.6,
135.2, 141.0, 147.3, 165.1; IR (KBr) mmax 3258, 2361, 1733, 1717,
1700, 1684, 1653, 1636, 1559, 1541, 1507, 1187, 1090, 863 cm−1;
MS (CI) m/z (rel. intensity) 230 [M(81Br) + H, 22], 228 [M(79Br) +
H, 22], 201 (100), 173 (25), 118 (18), 91 (53), 77 (36), 65 (36), 51
(33), 39 (42); Anal. calcd for C9H10NOBr: C, 47.39; H, 4.42; N,
6.14. Found: C, 47.61; H, 4.45; N, 5.98.
2-Bromo-4-methyl-6,7-dihydro-5H-[1]pyridine (11)
A solution of the 2-hydroxypyridine 44,15a (3.00 g, 20.1 mmol) in
phosphorus tribromide (4.5 mL, 47 mmol) was heated at reflux
for 12 h. The reaction mixture was then allowed to cool to room
temperature and was poured into an ice-cold aqueous solution
of sodium hydroxide (2 M, 300 mL). The resultant mixture was
extracted (gentle agitation to avoid emulsification) with ethyl
acetate (3 × 200 mL). The combined organic extracts were dried
over anhydrous sodium sulfate and concentrated in vacuo to afford
the crude product. Flash chromatography using chloroform as
the eluant afforded the title compound 11 (2.20 g, 52%) as a
colourless oil which crystallized upon standing. Mp 35–36 ◦C;
1H NMR (400 MHz, CDCl3) d 2.04–2.16 (2H, m, ArCH2CH2),
2.21 (3H, s, ArCH3), 2.80 (2H, apparent t, J = 7.5 Hz, ArCH2),
2.99 (2H, apparent t, J = 7.8 Hz, ArCH2), 7.05 (1H, s, ArH); 13
C
NMR (101 MHz, CDCl3) d 18.7, 25.9, 32.31, 74.9, 127.7, 135.3,
141.1, 147.4, 165.2; IR (KBr) mmax 2356, 2337, 1733, 1717, 1700,
1684, 1653, 1558, 1507, 1458, 1419, 1375, 1305, 1261, 1186, 1090,
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 877–885 | 883
©